Comparing J&J to CTUM is the sign of a desperate poster! It has tumbled, but mainly on low volume and zero news to support it at its higher levels. The long term prospects haven't changed a bit- I think recent additions to the team bode well for the PPS moving forward, but until there's some revenue from LFG or at least a license/approval from the EU or the FDA regarding LTC, we'll be lucky to trade sideways.
The short term problem now is that %100 gain from the close today puts us below the high of the year, but having bought at .041, I can wait out the dream. After all, I'm quite a few years younger than DR!!
Happy Holidays
